Sector

Indian pharma's growth expectations are trending downwards

The market grew by just 3.5 percent in November 2023. Lower price hikes and competition from generics are the main obstacles to higher growth

Unfavourable base drags domestic pharma sales growth to a low 3.5% in November

The domestic pharma's growth of 3.5 percent is the lowest monthly growth this year as a slowdown was seen across all key therapies

Crystal ball gazing: The winning investment themes for 2024

Renewables and export-oriented sectors such as chemicals, APIs, and IT figure among the eight themes for a rewarding investing journey in 2024 and beyond

PI Industries: Is value emerging or is it time to panic?

Pyroxasulfone has huge market demand and, given the patent protection for the next few years, we see limited impact on PI’s growth story

Why COP28 matters little for NTPC investors 

India’s dependence on coal-based power rose in April-November 2023 despite muted capacity additions

Solar project developers in a sweet spot over steady tariffs, falling costs

Solar module prices almost halved in the past one year

Max Healthcare: Should good health come at a cost?

Expansion plan supports growth momentum; however, valuations have turned quite high.

Will Bharat Electronics' annual orders surpass previous record?

The company received orders worth Rs 18,298 crore so far in FY24 against its annual guidance of Rs 20,000 crore

Aster DM Healthcare has its task cut out, post sale of GCC hospitals

The company should be able to close the gap in profit margins with India listed peers

Chart of the Day | The sticky problem plaguing IT services sector

Employee costs remain elevated despite a moderation in revenue growth

There are more steps to Medanta’s growth ladder

Demand for high-end healthcare facilities remains strong and Medanta is strategically cementing its footprint in north India.

Agrochemicals exporters' revenue weakness may spill over to 2024

Most global companies indicate continuing destocking pressures

Can green energy help NTPC realise its valuation potential?

The stock is up 51 percent in the last one year

Chart of the Day: Luxury housing props up affordability index

Sales in October 2023 are estimated to have risen by 19 percent in top seven cities

Vijaya Diagnostic Centre: How does it stand out in a crowded space?

A steady growth profile, strong regional presence, and a higher focus on radiology give the company an edge in a highly competitive industry

Behind pharma’s rebound is a good balancing act by drug producers

Complex and high value products are helping pharma companies overcome the price pressure in base generic drug business

Investors win in World Cup frenzy even as Indian fans nurse a loss

The 11-member MC Pro Cricindex has risen by 3 percent since September while the Nifty was flat during this period

Chart of the Day: Indigo hits a speed bump in October

The company’s market share declined by 80 basis points in October from September 2023

After balance sheet repair, the difficult part awaits Suzlon

The company has to rapidly grow its business volumes

Should investors look at luggage stocks to ride travel and wedding tailwinds?

While Safari is making the most of the opportunities, VIP remains in a weak spot

These two fertiliser stocks are marathon runners

Coromandel International and Paradeep Phosphates have multiple value-accretive catalysts.

Musk meeting miss may slow India’s EV run

Piyush Goyal’s proposed meeting with the Tesla boss could not take place, delaying the electric carmaker’s India investment plan

Apollo Hospitals: Profitability of non-hospital businesses a key watch

A credible profitability roadmap for pharmacy is the ask

PI Industries sticks with its growth momentum

PI Industries, with superior execution and a solid business model, is on track to achieve its long-term strategic objectives